Remove terms-of-use
article thumbnail

Advanced therapy CDMO Ascend nabs Florida manufacturing site and team from ocular gene therapy outfit Beacon

Fierce Pharma

As part of the deal, Ascend has also agreed to a long-term partnership with Beacon to produce its ocular gene therapies for clinical and commercial use. . | Ascend, which bills itself as a “total solutions gene therapy development partner,” has picked up the manufacturing team and site of Beacon Therapeutics in Alachua, Florida.

article thumbnail

Novo Nordisk’s Ozempic gets FDA label update flagging risk of intestinal blockage disorder

Fierce Pharma

While GLP-1 drugs from Novo Nordisk and Eli Lilly are believed to be relatively free of serious side effects, a few problems have emerged as the treatments have gained wider and longer-term use.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Potential Risk of Chronic Kidney Disease in Long Term Use of Acid Reducing Medications

Pharmacy Times

Pharmacists can use their knowledge and professional judgment to educate patients about when it is appropriate to take these medications and when to avoid them.

Medical 52
article thumbnail

Wegovy hype driving demand

World of DTC Marketing

There are also several physicians chiming in with their concerns over the long-term use of the drug. How many people will use the drug thinking they can eat what they want and not get exercise? Some were happy for any product that would help patients lose weight others were worried about the long-term use of the drug.

article thumbnail

CDMO acquires Meppel facility from Astellas

European Pharmaceutical Review

Meppel will be used to manufacture products for Astellas, according to the terms of the original agreement. “We are delighted to further expand our operations in the Netherland with this [third] site,” commented Nicolas Ragot, Managing Director of Delpharm. The financial terms of the transaction were not disclosed.

article thumbnail

Can we be serious about telehealth?

World of DTC Marketing

According to Healthcare Transformers, “ use of telehealth climbed more than 154% in late March 2020, compared with the year before, and a 2020 survey found 76% of patients would be interested in using it. The terms observation and inspection are often used interchangeably. There it is again. Why do patients lie?

Doctors 154
article thumbnail

10 Trends for online health seekers

World of DTC Marketing

IN SUMMARY: Online health seekers are using the Internet differently since the pandemic. Treatment options are researched more, and people are using, but not relying, on social media to gather information on what’s best for THEM. I estimate that the time searching and consuming online health information has increased by 54%.

Media 287